dalteparin has been researched along with Crohn Disease in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sbeit, W | 1 |
| Kadah, A | 1 |
| Shafrir, A | 1 |
| Kalisky, I | 1 |
| Mahamid, M | 1 |
| Hazou, W | 1 |
| Katz, L | 1 |
| Mari, A | 1 |
| Khoury, T | 1 |
1 other study available for dalteparin and Crohn Disease
| Article | Year |
|---|---|
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Awareness; Colitis | 2020 |